Xenetic Biosciences's market cap is currently $6.21M. The company's EPS TTM is $-2.647; its P/E ratio is ―; Xenetic Biosciences is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.54M	$ 1.71M	$ 1.16M	$ 436.94K	$ 17.07K
Gross Profit	$ 2.54M	$ 1.68M	$ 1.13M	$ 436.94K	$ 17.07K
Operating Income	$ -4.52M	$ -6.72M	$ -5.75M	$ 4.55M	$ -12.89M
EBITDA	$ -4.54M	$ -6.72M	$ -5.71M	$ -4.69M	$ -9.58M
Net Income	$ -4.13M	$ -6.39M	$ -5.54M	$ -10.89M	$ -15.95M
Balance Sheet
Cash & Short-Term Investments	$ 8.98M	$ 13.10M	$ 18.24M	$ 11.53M	$ 10.37M
Total Assets	$ 10.61M	$ 14.72M	$ 19.82M	$ 13.18M	$ 21.55M
Total Debt	$ 0.00	$ 0.00	$ 27.04K	$ 62.52K	$ 20.04K
Net Debt	$ -8.98M	$ -13.10M	$ -18.22M	$ -11.47M	$ -10.35M
Total Liabilities	$ 809.59K	$ 1.07M	$ 1.42M	$ 963.97K	$ 4.33M
Stockholders' Equity	$ 9.80M	$ 13.65M	$ 18.39M	$ 12.22M	$ 17.21M
Cash Flow
Free Cash Flow	$ -4.11M	$ -5.15M	$ -4.74M	$ -4.27M	$ -6.40M
Operating Cash Flow	$ -4.11M	$ -4.65M	$ -4.74M	$ -4.27M	$ -6.40M
Investing Cash Flow	$ 0.00	$ -500.00K	$ 0.00	$ 0.00	$ 2.00K
Financing Cash Flow	$ 0.00	$ 0.00	$ 11.45M	$ 5.43M	$ 16.13M

Currency in USD

Xenetic Biosciences Earnings and Revenue History

Income Statement >

Xenetic Biosciences Debt to Assets

Balance Sheet >

Xenetic Biosciences Cash Flow

Cash Flow >

Xenetic Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing